Guidelines for the approach to the patient with severe hereditary alpha-1-antitrypsin deficiency. American Thoracic Society.
D001993:Bronchodilator Agents / Q000627:therapeutic use; D005081:Exercise Therapy; D006801:Humans; D007509:Irritants / Q000009:adverse effects; D008168:Lung / Q000503:physiopathology; D008171:Lung Diseases / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D009316:National Institutes of Health (U.S.); D010349:Patient Compliance; D012042:Registries; D014481:United States; D000515:alpha 1-Antitrypsin / Q000009:adverse effects / Q000627:therapeutic use; D019896:alpha 1-Antitrypsin Deficiency
D001993:Bronchodilator Agents; D007509:Irritants; D000515:alpha 1-Antitrypsin